Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults

SIMPLE SUMMARY: Outcome of patients with Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) dramatically improved during the past 20 years with the advent of tyrosine kinase inhibitors and monoclonal antibodies. Their great efficacy in young and fit patients led to question our...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Khalil, Fernandez, Alexis, Pasquier, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997772/
https://www.ncbi.nlm.nih.gov/pubmed/35406576
http://dx.doi.org/10.3390/cancers14071805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997772/
https://www.ncbi.nlm.nih.gov/pubmed/35406576
http://dx.doi.org/10.3390/cancers14071805

Ejemplares similares